Olaris CEO, Dr. Elizabeth O'Day, contributes to USP's Trust or Consequences 2040 Report

Just weeks before COVID19 made headlines, Olaris CEO, Dr. Liz O'Day, collaborated with 100+ global experts to explore the future of medicine & healthcare. The project was a joint effort of U.S. Pharmacopeia and SupermindsMIT. A recurring theme between now and 2040 was the increasing frequency of global crises, like COVID-19. Read more in the full report, Trust or Consequences 2040, here.

May 22, 2020

Olaris CEO, Dr. Elizabeth O'Day, contributes to USP's Trust or Consequences 2040 Report